Fulgent Oncology
Don Corley is an accomplished executive with extensive experience in sales and business development within the healthcare and oncology sectors. As Executive Sales Director at Fulgent Oncology since June 2025, Corley collaborates with pathologists, oncologists, and lab directors to enhance the continuum of care through pathology and molecular testing. Previously, as Managing Partner at Venari Actif, Corley has focused on healthcare consulting and management of diagnostic testing. Corley's career includes notable roles such as Market Development Lead at Illumina, where efforts centered on advancing genomic technologies, and Vice President of Business Development at MolecularMatch, where strategies for clinical oncology decision support products were developed. Additionally, Corley has a solid foundation in strategic partnerships and business development from positions at Baylor Genetics and Baylor College of Medicine, and an early career that involved sales and marketing at WebMD/Healtheon. Corley holds a BBA in Business Administration, Finance, and Marketing from the University of Houston.
This person is not in any teams
This person is not in any offices
Fulgent Oncology
As a brand under Fulgent Genetics, Fulgent Oncology provides personalized cancer diagnostics services through CSI Laboratories and Inform Diagnostics, Fulgent Genetics subsidiaries. Together, our labs have helped pathologists and oncologists accurately diagnose and treat their patients for over 25 years. Our in-house medical team works closely with pathologists, oncologists and technicians to provide comprehensive diagnostic testing and analysis throughout the United States and Caribbean. We invest in an expert medical team, the right technology and equipment, and training to provide a higher level of service to customers. Our testing services include: Flow Cytometry, FISH, Cytogenetic Analysis, Histology and Molecular Genetics. We also provide hematopathology and surgical pathology consultations and second opinions to support diagnosis and treatment decisions. We understand the need to deliver accurate and fast test results and we are driven every day by our mission to provide personalized cancer diagnostics to support pathologists in providing care to cancer patients.